Co-Diagnostics, Inc. (CODX)
CODX Stock Price Chart
Explore Co-Diagnostics, Inc. interactive price chart. Choose custom timeframes to analyze CODX price movements and trends.
CODX Company Profile
Discover essential business fundamentals and corporate details for Co-Diagnostics, Inc. (CODX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Jul 2017
Employees
112.00
Website
https://co-dx.comCEO
Dwight Egan
Description
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
CODX Financial Timeline
Browse a chronological timeline of Co-Diagnostics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 14 Aug 2026
EPS estimate is -$3.00, while revenue estimate is $132.58k.
Earnings released on 14 May 2026
EPS came in at -$4.06 falling short of the estimated -$3.75 by -8.27%, while revenue for the quarter reached $145.95k , beating expectations by +14.88%.
Earnings released on 31 Mar 2026
EPS came in at -$16.35 falling short of the estimated -$3.60 by -354.17%, while revenue for the quarter reached $262.49k , beating expectations by +108.52%.
Stock split effective on 2 Jan 2026
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2025
EPS came in at -$4.80 surpassing the estimated -$5.71 by +15.94%, while revenue for the quarter reached $145.38k , beating expectations by +15.38%.
Earnings released on 14 Aug 2025
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%, while revenue for the quarter reached $162.91k , missing expectations by -45.70%.
Earnings released on 8 May 2025
EPS came in at -$0.24 surpassing the estimated -$0.33 by +27.27%, while revenue for the quarter reached $50.28k , missing expectations by -73.19%.
Earnings released on 27 Mar 2025
EPS came in at -$0.36 falling short of the estimated -$0.34 by -5.88%, while revenue for the quarter reached $149.33k , missing expectations by -60.18%.
Earnings released on 7 Nov 2024
EPS came in at -$0.32 surpassing the estimated -$0.33 by +3.03%, while revenue for the quarter reached $641.14k , beating expectations by +70.97%.
Earnings released on 8 Aug 2024
EPS came in at -$0.25 surpassing the estimated -$0.34 by +26.47%, while revenue for the quarter reached $2.66m , beating expectations by +618.06%.
Earnings released on 9 May 2024
EPS came in at -$0.31 falling short of the estimated -$0.21 by -47.62%, while revenue for the quarter reached $252.75k , missing expectations by -91.71%.
Earnings released on 14 Mar 2024
EPS came in at -$0.50 falling short of the estimated -$0.20 by -150.00%, while revenue for the quarter reached $3.56m , missing expectations by -1.79%.
Earnings released on 9 Nov 2023
EPS came in at -$0.20 surpassing the estimated -$0.29 by +31.03%, while revenue for the quarter reached $2.46m , missing expectations by -31.75%.
Earnings released on 10 Aug 2023
EPS came in at -$0.31 falling short of the estimated -$0.24 by -29.17%, while revenue for the quarter reached $197.81k , missing expectations by -60.44%.
Earnings released on 11 May 2023
EPS came in at -$0.20 surpassing the estimated -$0.23 by +13.04%, while revenue for the quarter reached $601.96k , missing expectations by -45.28%.
Earnings released on 16 Mar 2023
EPS came in at -$0.32 falling short of the estimated -$0.15 by -113.33%, while revenue for the quarter reached $1.40m , missing expectations by -74.52%.
Earnings released on 10 Nov 2022
EPS came in at -$0.04 surpassing the estimated -$0.06 by +33.33%, while revenue for the quarter reached $5.09m , missing expectations by -31.92%.
Earnings released on 11 Aug 2022
EPS came in at -$0.10 falling short of the estimated $0.15 by -166.67%, while revenue for the quarter reached $5.02m , missing expectations by -67.26%.
Earnings released on 12 May 2022
EPS came in at $0.26 surpassing the estimated $0.18 by +44.44%, while revenue for the quarter reached $22.70m , beating expectations by +7.24%.
Earnings released on 24 Mar 2022
EPS came in at $0.25 surpassing the estimated $0.15 by +66.67%, while revenue for the quarter reached $20.40m , missing expectations by -2.54%.
Earnings released on 11 Nov 2021
EPS came in at $0.38 surpassing the estimated $0.21 by +80.95%, while revenue for the quarter reached $30.10m , beating expectations by +41.41%.
Earnings released on 12 Aug 2021
EPS came in at $0.33 surpassing the estimated $0.23 by +43.48%, while revenue for the quarter reached $27.36m , beating expectations by 0.00%.
CODX Stock Performance
Access detailed CODX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
